pembrolizumab,nivolumab
merck,bms
['nivo', 'pembro']
more than just pembro nivo et al.: other frontiers of cancer-directed #immunotherapy, including #celltherapy, reviewed in immuno-oncology clinical trials take a turn beyond pd1/pdl1 inhibitors
#aacr23 
Physician-Scientist/Clinical Cancer Biologist. Clinical focus: GI Cancers/Neuro-Oncology. In lab: #TunnelingNanotubes and other drivers of La ChemoResistance